Standout Papers
- CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability (2010)
- Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity (2010)
- OncogenicCSF3RMutations in Chronic Neutrophilic Leukemia and Atypical CML (2013)
Immediate Impact
3 by Nobel laureates 35 from Science/Nature 65 standout
Citing Papers
The changing landscape of atherosclerosis
2021 StandoutNature
Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
2020 Standout
Works of Marc Loriaux being referenced
Survey of Activated FLT3 Signaling in Leukemia
2011
Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
2010 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Marc Loriaux | 2158 | 2060 | 1956 | 96 | 4.5k | |
| Christopher A. Eide | 2258 | 1527 | 1556 | 92 | 3.8k | |
| Nikolas von Bubnoff | 1933 | 1309 | 1102 | 134 | 4.0k | |
| Ronald Paquette | 3179 | 2321 | 1509 | 117 | 4.9k | |
| Philip Beer | 2223 | 2674 | 2336 | 86 | 4.5k | |
| Katherine R. Calvo | 2311 | 1378 | 1621 | 140 | 4.9k | |
| Johan Richter | 1683 | 1133 | 1502 | 141 | 4.1k | |
| Taghi Manshouri | 3064 | 3113 | 2995 | 140 | 6.1k | |
| Thomas Mercher | 1934 | 1904 | 2341 | 53 | 3.9k | |
| Y. Lynn Wang | 1044 | 1756 | 1494 | 109 | 3.4k | |
| Clayton A. Smith | 2837 | 1110 | 2665 | 128 | 5.3k |
All Works
Loading papers...